Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1α in skeletal



















































The sirtuin family of proteins possesses NAD
+-
dependent deacetylase activity and/or ADP ribosyltrans-



















































sirtuins (SIRT1-7) are localized differentially within the 
cell and have a variety of functions [1, 2]. SIRT1 is the 
most extensively studied member of the family and 
regulates diverse biological processes ranging from 
DNA repair and genome stability to glucose and lipid 










































1α  up‐regulation.  Furthermore,  we  show  that  SIRT3  is  more  highly  expressed  in  slow  oxidative  type  I  soleus  muscle
compared to fast type II extensor digitorum longus or gastrocnemius muscles. Additionally, we find that SIRT3 protein
levels in skeletal muscle are sensitive to diet, for SIRT3 expression increases by fasting and caloric restriction, yet it is
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SIRT3-5, are found in the mitochondria [5, 6], not much 
is known about their function in vivo [7]. SIRT4 has 
been shown to regulate amino acid-stimulated insulin 
secretion by targeting glutamate dehydrogenase [8], and 
it was recently demonstrated that SIRT5 participates in 
the urea cycle [9]. Among the mitochondrial sirtuins, 
SIRT3 possesses the most robust deacetylase activity 
[10-12]. Indeed, significantly higher levels of 
mitochondrial protein acetylation were detected in the 
livers of SIRT3-null mice, compared to those of SIRT4 
or SIRT5 knockout animals [13]. However, little is 
known about the physiological role of SIRT3 despite 
the fact that a number of SIRT3 substrates and co-
precipitating proteins have been identified: acetyl-CoA 
synthetase 2 [14], Ku70 [15], FOXO3a [16], subunit 9 
of mitochondrial Complex I (NDUFA9) [17], glutamate 
dehydrogenase [13, 18] and isocitrate dehydrogenase 2 
[18]. 
 
SIRT3 has been linked to longevity in men [19, 20] and 
aberrant expression of this sirtuin correlates with node-
positive breast cancer in clinical biopsies from women 
[21]—suggesting that SIRT3 serves as an important 
diagnostic and therapeutic target in human health/aging 
and disease, affecting men and women in unique ways. 
In human cells, we have shown that SIRT3, along with 
SIRT4, is required for Nampt-mediated cell survival 
after genotoxic stress, wherein maintenance of 
mitochondrial NAD
+ levels inhibits apoptosis [22]. 
Previously we also reported in murine brown adipose 
tissue that the RNA level of SIRT3 increases by cold 
exposure and caloric restriction (CR) and that 
constitutive expression of SIRT3, in brown pre-
adipocytes, stimulates downstream CREB-mediated 
expression of PGC-1α and other mitochondrial-related 
genes [10]. In this study, we investigated the 
physiological conditions that regulate SIRT3 in skeletal 
muscle, a metabolically active organ vital for insulin-
mediated glucose disposal and lipid catabolism. 
Notably, skeletal muscle strongly influences whole-
body lipid metabolism, as lipid catabolism provides up 
to 70% of the energy usage for resting muscle [23]. In 
this tissue, the balance between fatty acid availability 
and fatty acid oxidation rates plays an important role in 
regulating insulin responses, and intramuscular fatty 
acid metabolites like diacylglycerol may cause insulin 
resistance [24]. Therefore, studying the role of 
molecular factors and pathways acting in muscle under 
various dietary and environmental conditions will be 
critical for better understanding metabolism, health, and 
disease.  
 
In skeletal muscle, the peroxisome proliferator-activated 
receptor gamma coactivator-1α (PGC-1α), a nuclear 
receptor co-activator, plays multiple roles in metabolic 
regulation [25, 26]. It stimulates mitochondrial 
biogenesis [27], induces muscle fiber-type switch, and 
increases oxidative capacity in skeletal muscle cells 
[28]. In addition to transcriptional activation by CREB 
[29], it has been shown that AMP-activated protein 
kinase (AMPK) also increases PGC-1α expression [30, 
31] and activates it by direct phosphorylation [32]. 
AMPK is also a key molecular sensor and regulator of 
muscle metabolism.  
 
AMPK is a ubiquitous heterotrimeric serine/threonine 
protein kinase, which functions as a fuel sensor in many 
tissues, including skeletal muscle [33]. AMPK is 
allosterically activated by AMP and by phosphorylation 
at Thr172 in the catalytic α-subunit, mainly by an 
upstream AMPK kinase, LKB1 [34, 35]. Importantly, 
AMPK is stimulated by cellular stresses that deplete 
ATP and elevate AMP, such as diet restriction/hypo-
glycemia [36], exercise [37], and muscular contraction 
[38]. Activated AMPK stimulates ATP-generating 
catabolic pathways, such as cellular glucose uptake and 
fatty acid α-oxidation. AMPK activation also represses 
ATP-consuming processes, such as lipogenesis, to 
restore intracellular energy balance [33, 39]. 
 
Our work seeks to further elucidate the role of sirtuins 
within health and disease, with particular focus on 
muscle tissue in this study. We report here that 
expression of SIRT3 in skeletal muscle is sensitive to 
various signals from both diet and exercise, leading to 
downstream activation of AMPK and up-regulation of 
PGC-1α. SIRT3 is therefore a potential key regulator of 
skeletal muscle biology, responding to important 




SIRT3 is regulated in skeletal muscle by exercise 
training  
 
We first assayed the SIRT3 expression profile in vivo to 
compare the whole-body distribution of SIRT3, 
specifically across muscles to tissues like adipose and 
kidney, where SIRT3 has been previously described. As 
predicted, the SIRT3 tissue distribution pattern mirrors 
that of SIRT3 mRNA [11]. Indeed, SIRT3 exhibits high 
expression in important metabolically active tissues like 
kidney, brown fat, liver, and brain (Figure 1). When 
comparing expression across muscle samples, we 
noticed that SIRT3 protein levels were higher in the 
slow-twitch soleus muscle compared to the fast-twitch 
muscles like extensor digitorum longus and gastro-
cnemius, in agreement with higher mitochondrial 
content and the oxidative feature of the soleus muscle. 
 
 
























To study the role of SIRT3 in muscle within the context 
of exercise biology, we next tested if SIRT3 protein 
levels were sensitive to an established voluntary 
exercise protocol [40]. Using a specific anti-mouse 
SIRT3 polyclonal antibody, we found that SIRT3 
protein increased selectively in triceps, the muscle that 
undergoes training in the wheel-caged system, but not 
in cardiac muscle samples from those same animals 
(Figure 2A). In contrast to SIRT3, exercise training 
failed to alter SIRT1 protein levels in triceps (data not 
shown). The specificity of our antibody for detecting 
the endogenous ~28kDa SIRT3 protein was confirmed 
by using SIRT3 knockout tissue lysates (Supplemental 
Figure 1). Notably, induction of SIRT3 in skeletal 
muscle was higher in female mice when compared to 
that of male littermates (Figure 2B). In agreement with 
this up-regulation, we also observed increased SIRT3 
levels in the gastrocnemius muscle of rats exercised on 
a treadmill-based exercise paradigm [41] (Supplemental 
Figure 2). Even one week of treadmill training was 
sufficient to increase SIRT3 protein amount 
(Supplemental Figure 2B). The up-regulation of SIRT3 
(Figure 2B) correlated with enhanced downstream 
phosphorylation of CREB at Ser133 (Figure 2C) and 
PGC-1α induction (Figure 2D). Lastly, citrate synthase 
activity, a mitochondrial marker for exercise training, 
was significantly higher in trained muscles than in the 
respective sedentary control group (Figure 2E). 
Collectively, these data suggest that the up-regulation of 
SIRT3 by exercise is an important and conserved 
































SIRT3 expression in skeletal muscle is sensitive to 
dietary intake  
 
Previously we had demonstrated how CR stimulates the 
in vivo expression of SIRT3 in brown fat [10]. Thus we 
hypothesized that perhaps SIRT3 expression in muscles 
is also sensitive to nutritional signals, especially given 
how different muscles contain various levels of SIRT3 
(Figure 1) and vary inherently with respect to 
energetic/metabolic potential. To test this hypothesis, 
we measured the SIRT3 levels in leg muscles of mice in 
either CR or ad libitum (AL) cohorts after twelve 
months. CR is an effective environmental method 
known to extend lifespan in a number of model 
organisms, from yeast and nematodes to rodents, yet the 
underlying molecular mechanisms by which this 
pathway acts in vivo remain largely unknown [42]. 
 
Here we found that the CR diet significantly increased 
levels of SIRT3 protein in skeletal muscle, compared to 
the AL control diet (Figure 3A). In addition, twenty-
four hours of fasting was sufficient to induce the muscle 
expression of SIRT3 (Figure 3B). Conversely, SIRT3 
protein level was significantly decreased following 
three months of energy-dense, high-fat feeding (Figure 
3C), indicating that the SIRT3 expression in muscle 
fluctuates in response to dietary nutrient uptake. We 
next measured the effect of CR on AMPK—an enzyme 
whose activity is dependent on changes in metabo-
lic/energetic potential [30, 31].  
 
 














































Since AMPK is activated during decreased energy 
levels, we hypothesized that AMPK may be activated 
under CR. In nematodes, for example, it has recently 
been shown that AMPK is critical for mediating key 
downstream biological effects that enable lifespan 
extension by caloric/dietary restriction [43]. Our data 
here show that AMPK is hyper-phospho-activated at 
Thr172 of its catalytic α-subunit, which was quantified 

























































AL control diet (Figure 3D). Together these data 
provided novel connections between caloric intake, 
SIRT3 and AMPK that merit more analysis.  
 
Loss of SIRT3 significantly impacts activation of 
AMPK, CREB and PGC-1α expression 
 
We next tested if the lack of SIRT3 would impact 
AMPK and other related factors like CREB and/or 
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data, we found that SIRT3-null animals had 50% lower 
levels of AMPK phosphorylation compared to the wild-
type littermate control group (Figure 4A). In our exercise 
model (Figure 2A-D), SIRT3 up-regulation enhanced 


















































ingly, in the SIRT3-null mice, activating phosphorylation 
of CREB at Ser122 was also reduced (Figure 4B), which 
correlated with lowered transcriptional activation of pgc-
1α (Figure 4C). This result is consistent with previously 
published data, which show that both AMPK and CREB 





























































































Here we have found that SIRT3 is differentially 
expressed in vivo, with the greatest expression observed 
in metabolically active tissues like skeletal muscle, 
where SIRT3 undergoes dynamic regulation by 
different environmental regimens. SIRT3 protein level 
is decreased by high-fat feeding, while it is increased by 
short-term fasting (24-hour) or long-term nutrient 
deprivation (12-month CR) and exercise training. In this 
study we also show that loss of SIRT3 significantly 
inhibits AMPK and CREB phosphorylation, which 
decreases PGC-1α transcriptional expression in muscle. 
Consequently, we propose a new model in which SIRT3 
leads to potential downstream changes in response to 
































(B)  CREB  phosphorylation  and  CREB  total  protein  in  the  EDL  muscles  of  the  wild‐type  mice  or  mice  with
heterozygous  or  homozygous  SIRT3  gene  deficiency  were  determined  by  Western  blotting  analysis.  CREB














suggests that SIRT3 levels may respond to various 
nutritional/energetic and physiological challenges by 
regulating muscle energy homeostasis via factors like 
AMPK and PGC-1α. 
 
Given our study, it will be interesting to test whether 
SIRT3-null animals show any defects under certain 
environmental challenges. Despite the hyper-acetylation 
of mitochondrial proteins in SIRT3 knockout mice, the 
significance of these biochemical changes is unclear. A 
recent study of SIRT3-deficient mice by another group 
did not find defects in basal metabolism nor adaptive 
thermogenesis, while the mice were housed in standard 
dietary/sedentary conditions [13]. Similarly, we found 
normal treadmill performance in SIRT3 knockout mice 
while under standard housing (unpublished observa-
tions). Upon challenge with various environmental 
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differently. Accordingly, we are actively testing how 
challenges by CR/fasting/high-fat diet and exercise may 
affect the SIRT3-null mice and alter key downstream 
cellular factors in muscle cells. 
 
The mechanism(s) by which different environmental 
variables modulate SIRT3 and activate AMPK in muscle 
(and other tissues that highly express SIRT3) remains to 
be fully elucidated. For example, activation of acetyl-
CoA synthetase 2 (AceCS2) by SIRT3 [44, 45] may 
elevate the AMP/ATP ratio and consequently activate 
AMPK. Alternatively, a recent proteomics-based 
approach has identified many novel SIRT3-interacting 
partners in human cells, including the ATP synthase 
(mitochondrial F1 complex) alpha/beta subunits and the 
ubiquinol-cytochrome c reductase hinge protein, UQCRH 






































serve as critical components of the ATP-generating 
machinery in cells, SIRT3 may also potentially modulate 
the AMP/ATP ratio via these factors to activate AMPK. 
Moreover, we too have purified additional putative 
SIRT3-binding proteins from HeLa cells (using a related 
cross-linking/immunoaffinity  purification method [47]), 
which include mitochondrial acetoacetyl CoA thiolase 
(also referred to as α-ketothiolase), malate dehydro-
genase, thioredoxin 2 (Trx-2), Hsp60, and lactate 
dehydrogenase (unpublished data). Since some of these 
enzymes are important regulators of muscle energy 
homeostasis, our data further substantiate that SIRT3 
may modulate ATP/energy levels via key targets to 
activate AMPK. It is intriguing to note that a study of an 
independent line of SIRT3-knockout mice indicated that 
the ATP level is significantly reduced in several tissues 
[17], although the effect of SIRT3 deficiency on muscle 































Figure  5.  Schematic  diagram  of  potential  SIRT3  action  in  the  skeletal  myocyte.
Collectively, our data support a working model in which SIRT3 responds dynamically to various
nutritional and physiological signals to potentially impact muscle energy homeostasis via AMPK and
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AMPK, upon glucose nutrient restriction of muscle 
stem cells, causes an increase in the cellular 
NAD
+/NADH ratio, consistent with a positive feedback 
loop needed for prolonged SIRT1 activation [48], as 
may occur in our SIRT3 model and merits testing. 
Indeed a second in vitro study independently validates a 
similar NAD
+/NADH model via AMPK [49]. 
Strikingly, AMPK activation (as occurs with CR) may 
also result in lifespan extension [50-52], and future 
study will reveal if SIRT3 is involved in this process. It 
is known that activated AMPK directly phosphorylates 
PGC-1α [32] and CREB [53]—and that both AMPK 
and CREB are involved in the transactivation of PGC-
1α [54, 55]. Lastly, both SIRT3 and SIRT1 promote 
mitochondrial biogenesis and fatty acid oxidation via 
PGC-1α but in different ways. SIRT3 promotes PGC-
1α expression while SIRT1 activates PGC-1α by direct 
deacetylation [56]. However, we have found that 
exercise training regulates SIRT3 but not SIRT1 
expression in muscle. At present, it remains to be 
considered how these two key sirtuin enzymes may 
work cooperatively within certain tissues in response to 
environmental signals. 
 
Furthermore, it is important to consider that a 
phenotype may be tissue-specific, especially if SIRT3 
has different biological roles in the body. For example, 
in the rennin-angiotensin system, which plays a key role 
in the pathophysiology of cardiac and renal disease in 
humans, targeted disruption of the angiotensin receptor 
(Agtr1a gene in mice) yields animals with less cardiac 
and vascular injury, prolonged lifespan, increased 
number of mitochondria, and dramatic up-regulation of 
SIRT3 in kidney tissue—a possible site of SIRT3 action 
that may contribute, at least in part, to the phenotype 
that is observed [57]. Another interesting place of 
molecular action is in brown adipose tissue (BAT), in 
which SIRT3 has been previously shown to respond 
dynamically to CR and regulate fat cell physiology via 
PGC-1α [10]. With the recent discovery of BAT in 
humans (reviewed in [58]), there are now new 
opportunities to explore the role of SIRT3 in diabetes 
and obesity research [59]. Moreover, after intense 
swimming, it has been reported that the expression of 
SIRT3 and PGC-1α increases in white blood cells to 
activate the antioxidant response [60]. Lastly, in human 
skeletal muscle, it has been reported that SIRT3 and 
PGC-1α expression decline with age and correlate with 
a sedentary proteomic profile found in people with 
decreased metabolic output [61]. With exercise, 
however, these authors observed that the effect is 
reversed. Collectively, these data suggest that SIRT3 
function is perhaps varied throughout the body and 
specialized to meet the unique metabolic/energetic 
capacities found within various tissues, particularly in 
response to environmental cues. 
 
Thus it will be interesting to test whether inducible 
tissue-specific SIRT3-null mice show global metabolic 
defects from exercise and/or diet regimens in various 
parts of the body, especially with aging. This inducible 
genetic approach will also allow us to bypass potential 
compensatory effects resulting from the lack of SIRT3 
during development. Additionally, a mouse model with 
increased SIRT3 over-expression in muscle (and/or 
other specific tissues) will also be a valuable tool for 
further elucidating the biological role(s) of this sirtuin in 
vivo. All of this work will be important as we fight 
against aging and associated disorders ranging from 
type 2 diabetes (and other metabolic diseases) to breast 
cancer, in which expression of SIRT3 is aberrant. 
Therefore, small-molecule activators of SIRT3, 
currently in development and testing [62], may provide 
novel and key therapeutic routes for the treatment of a 
variety of common diseases, perhaps by mimicking the 
beneficial molecular effects of exercise and/or caloric 




Animals, diet and exercise. Ethics statement: Protocols 
for animal use were in accordance with the guidelines 
of the Institutional Animal Care and Use Committees of 
Baylor College of Medicine and the Joslin Diabetes 
Center and the National Institutes of Health. For the 
caloric restriction experiment, C57BL/6 male mice were 
singly caged. At 8 weeks of age, control mice were fed 
ad libitum with NIH-31 standard diet (Harlan Teklad), 
while food consumption was measured daily. Caloric 
restricted mice were fed with NIH-31/NIA-fortified diet 
(Harlan Teklad) with a daily food allotment of 90%, 
70% and then 60% of the amount consumed by the 
control mice—at the first, second, and third week, 
respectively. From then on, daily food allotment 
stabilized at 60% of ad libitum food intake for the 
caloric restricted mice. 12 months later, mice were 
dissected to collect tissues for analysis. For the fasting 
experiment, food was removed from 3 months old 
C57BL/6 male mice at 6pm for 24 hours. For the high-
fat diet feeding experiment, 8-week-old male mice were 
fed a control diet or a 35% fat-enriched chow (Bio-
Serv) for three months. Various tissues
  were also 
harvested from mice fed the control diet to examine 
SIRT3 gene expression by Western
 blot analysis at the 
termination of the study. For the exercise study [40], 7-
week-old male and female FVB/NJ mice were wheel-
cage trained for 6 weeks and fed PicoLab Mouse Diet 
20 (LabDiet/Purina). In brief, mice were housed in 
individual cages with or without rodent running wheels 
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voluntarily during a 6-week training period. At the end of 
the 6 weeks, mice were euthanized, triceps muscles were 
removed and subsequently analyzed for SIRT3, CREB, 
phospho-CREB/Ser122, and PGC-1α protein expression 
[10]. Citrate synthase activity was measured as a 
mitochondrial marker post-exercise training from triceps 
samples, as described previously [40]. 
 
Sirt3-knockout mice. Mice in which the Sirt3  gene 
(Accession: NM_022433) was targeted by gene 
trapping were obtained from the Texas Institute for 
Genomic Medicine (Houston, TX, USA). Briefly, these 
mice were created by generating embryonic stem (ES) 
cells (Omnibank No. OST341297) with a retroviral 
promoter trap that functionally inactivates one allele
 of 
the Sirt3 gene, as described previously [63]. Sequence
 
analysis indicated that retroviral insertion occurred in 
the intron preceding coding exon 2 (Supplemental 
Figure 1). Targeted 129/SvEvBrd embryonic stem cells 
were injected into C57BL/6 albino blastocysts. The 
chimeras (129/SvEvBrd) were then crossed with 
C57BL/6 albinos to produce the heterozygotes. 
Heterozygotes were then mated and the offspring were 
genotyped using PCR, containing two primers flanking 
the trapping cassette insertion site TG0003-5' 
(ATCTCGCAGATAGGCTATCAGC) and TG0003-3' 
(AACCACGTAACCTTACCCAAGG), as well as a 
third primer LTR rev, a reverse primer located at the 5’ 
end of the trapping cassette (ATAAACCCTCTTGCAG 
TTGCATC). Primer pair TG0003-5’ and TG0003-3’ 
amplify a 336bp fragment from the wild-type allele, 
while primer pair TG0003-5’ and LTR rev amplify a 
160bp fragment from the knockout allele. 
 
Antibodies and Western blots. The antibodies used for 
Western blot analysis included: anti-mouse SIRT3 
serum raised against the C-terminus (DLMQRERGKLD 
GQDR, Genemed Synthesis, Inc.) and used for the 
tissue distribution and high-fat diet analyses; anti-mouse 
and anti-rat SIRT3 serum was also developed against 
the C-terminal regions of each respective protein 
(Covance), and the anti-mouse serum was validated for 
specificity using brown fat, cardiac tissue, and soleus 
muscle from SIRT3 knockout mice (Supplemental Fig. 
1), then used for analyzing the exercise samples. Other 
antibodies used included the following: anti-phospho-
CREB/Ser133 (Cell Signaling); anti-CREB (Cell 
Signaling); anti-phospho-AMPK (Cell Signaling); 
AMPK (Cell Signaling); anti-PGC-1α (Calbiochem); β-
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